|
|
||||||||
B Activation1



Departments of
*
Biochemistry and Molecular Biology,
Pharmacy, and
Surgery, College of Medicine, Yeungnam University, Taegu, South Korea; and
§
Department of Immunology, School of Medicine, Keimyung University, Taegu, South Korea.
The effect of secretory group II phospholipase A2
(sPLA2) on the expression of the inducible NO synthase
(iNOS) and the production of NO by macrophages was investigated.
sPLA2 by itself barely stimulated nitrite production and
iNOS expression in Raw264.7 cells. However, in combination with LPS,
the effects were synergistic. This potentiation was shown for
sPLA2 enzymes from sPLA2-transfected stable
cells or for purified sPLA2 from human synovial fluid. The
effect of PLA2 on iNOS induction appears to be specific for
the secretory type of PLA2. LPS-stimulated activation of
iNOS was inhibited by the well-known selective inhibitors of
sPLA2 such as 12-epi-scalaradial and
-bromophenacyl
bromide. In contrast, the cytosolic PLA2-specific
inhibitors methyl arachidonyl fluorophosphate and
arachidonyltrifluoromethyl ketone did not affect LPS-induced nitrite
production and iNOS expression. Moreover, when we transfected
cDNA-encoding type II sPLA2, we observed that the
sPLA2-transfected cells produced two times more nitrites
than the empty vector or cytosolic PLA2-transfected cells.
The sPLA2-potentiated iNOS expression was associated with
the activation of NF-
B. We found that the NF-
B inhibitor
pyrrolidinedithiocarbamate prevented nitrite production, iNOS
induction, and mRNA accumulation by sPLA2 plus LPS in
Raw264.7 cells. Furthermore, EMSA analysis of the activation of the
NF-
B involved in iNOS induction demonstrated that
pyrrolidinedithiocarbamate prevented the NF-
B binding by
sPLA2 plus LPS. Our findings indicated that
sPLA2, in the presence of LPS, is a potent activator of
macrophages. It stimulates iNOS expression and nitrite production by a
mechanism that requires the activation of
NF-
B.
This article has been cited by other articles:
![]() |
J.-H. Chen, H.-H. Lin, T.-A. Chiang, J.-D. Hsu, H.-H. Ho, Y.-C. Lee, and C.-J. Wang Gaseous Nitrogen Oxide Promotes Human Lung Cancer Cell Line A549 Migration, Invasion, and Metastasis via iNOS-Mediated MMP-2 Production Toxicol. Sci., December 1, 2008; 106(2): 364 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xie, L. Liu, X. Huang, Y. Guo, and L. Lou Scalaradial Inhibition of Epidermal Growth Factor Receptor-Mediated Akt Phosphorylation Is Independent of Secretory Phospholipase A2 J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1210 - 1217. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Jo, H.-Y. Lee, Y.-N. Lee, J. I. Kim, H.-K. Kang, D.-W. Park, S.-H. Baek, J.-Y. Kwak, and Y.-S. Bae Group IB Secretory Phospholipase A2 Stimulates CXC Chemokine Ligand 8 Production via ERK and NF-{kappa}B in Human Neutrophils J. Immunol., November 15, 2004; 173(10): 6433 - 6439. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W.M Niessen, P. A.J Krijnen, C. A Visser, C. J.L.M Meijer, and C Erik Hack Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes? Cardiovasc Res, October 15, 2003; 60(1): 68 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, G. Zhao, and Z. Dong Phosphatidylcholine-specific phospholipase C regulates activation of RAW264.7 macrophage-like cells by lipopeptide JBT3002 J. Leukoc. Biol., June 1, 2001; 69(6): 1060 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Anthonsen, A. Solhaug, and B. Johansen Functional Coupling between Secretory and Cytosolic Phospholipase A2 Modulates Tumor Necrosis Factor-alpha - and Interleukin-1beta -induced NF-kappa B Activation J. Biol. Chem., August 3, 2001; 276(32): 30527 - 30536. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |